BIO-Europe Spring 2026 brought together more than 3,700 innovators in the life sciences industry all under the same roof.
A U.S. Patent Office tribunal has ruled against Nobel Prize-winning scientists Jennifer Doudna and Emmanuelle Charpentier for ...
The COVID pandemic ushered mRNA vaccines into the spotlight, and the technology has even greater potential. Here’s what to ...
In a win for the rare disease space, the U.S. FDA granted accelerated approval for Rocket Pharmaceuticals Inc.’s Kresladi (marnetegragene autotemcel) as the first gene therapy option for treating ...
Rocket Pharmaceuticals (RCKT) stock jumps as FDA approves its gene therapy Kresladi for a rare immune disease called ...
A new study by UCLA Health published in Cell presents a major advancement in the future of personalized medicine by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results